Please login to the form below

Not currently logged in
Email:
Password:

Valeant appoints Howard Schiller to the board

He joins at a time of expansion for the Canadian pharma company

Howard Schiller ValeantValeant Pharmaceuticals has appointed its chief financial officer Howard Schiller to its board of directors.

Schiller has been with Valeant since December 2011, also serving as executive VP in that period.

He joined after retiring from Goldman Sachs, where he was chief operating officer for the investment banking division responsible for the management and strategy of the business.

"Since Howard joined Valeant, his valuable experience and sound counsel have been invaluable to both Valeant's management team and the board of directors," said J Michael Pearson, chair and CEO.

“Appointing him to our board is the next logical step and one I believe will benefit our shareholders."

He joins the board at a time of great expansion for the Canadian pharma company, with several major acquisitions during the past couple of years including gum disease specialists OraPharma, footcare specialist Pedinol and, most recently, a $2.6bn deal to purchase dermatology company Medicis Pharmaceutical.

In addition to his roles at Valeant, Schiller is on the New York board of Teach for America and on the board of the Cancer Research Institute.

24th September 2012

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Market Study Report

Market Study Report is a hub for market intelligence products and services. We streamline the purchase of your market research...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics